Adrenoleukodystrophy (X-ALD) Astrocyte Mitochondrion Peroxisomal disorder Reactive oxygen species Very long chain fatty acids (VLCFA) X-linked adrenoleukodystrophy (X-ALD) is a severe neurodegenerative disorder resulting from defective ABCD1 transport protein. ABCD1 mediates peroxisomal uptake of free very-long-chain fatty acids (VLCFA) as well as their CoA-esters. Consequently, VLCFA accumulate in patients' plasma and tissues, which is considered as pathogenic X-ALD triggering factor. Clinical symptoms are mostly manifested in neural tissues and adrenal gland. Here, we investigate astrocytes from wild-type control and a genetic X-ALD mouse model (Abcd1-knockout), exposed to supraphysiological VLCFA (C22:0, C24:0 and C26:0) concentrations. They exhibit multiple impairments of energy metabolism. Furthermore, brain mitochondria from Abcd1 −/− mice and wild-type control respond similarly to VLCFA with increased ROS generation, impaired oxidative ATP synthesis and diminished Ca 2+ uptake capacity, suggesting that a defective ABCD1 exerts no adaptive pressure on mitochondria. In contrast, astrocytes from Abcd1 −/− mice respond more sensitively to VLCFA than wild-type control astrocytes. Moreover, longterm application of VLCFA induces high ROS generation, and strong in situ depolarization of mitochondria, and, in Abcd1 −/− astrocytes, severely diminishes the capability to revert oxidized pyridine nucleotides to NAD(P)H.
The mouse model for X-ALD, the Abcd1-knockout mouse, which was developed independently in three laboratories [12] [13] [14] displays biochemical abnormalities, like reduced VLCFA β-oxidation and accumulation of VLCFA, similar to the situation seen in patients. However, Abcd1-knockout mice develop a late onset neurological phenotype that resembles the AMN phenotype and not cALD [15] .
Like in other peroxisomal diseases, the molecular mechanism of the X-ALD pathogenesis is still elusive. There are two different research paradigms to uncover the X-ALD pathogenesis. Impairment of axonal function by demyelination is a hallmark of several neurodegenerative diseases caused by mutated peroxisomal proteins, most prominently in X-ALD or the Refsum syndrome. According to one view, oligodendrocytes with impaired peroxisomes fail to support white matter maintenance. This is probably due to the peroxisomal failure to provide oligodendrocytes with essential neuroprotective functions in order to protect against axon degeneration and neuroinflammation [16] . This conclusion is based on reports showing that peroxisomes may function to inactivate reactive oxygen species (ROS) in cells, such as oligodendrocytes [17] . Nevertheless, peroxisomes may also be considered as a main source of the generation of cellular ROS [18] . Moreover, a clear correlation between enhanced tissue levels of VLCFA and inflammatory disease progression in childhood X-ALD has been reported [19] .
In addition, it has been claimed that oxidative stress is the major factor in the pathogenesis of X-ALD [20] [21] [22] [23] [24] ; and in mitochondrial permeability transition pore (PTP) function [25] . Moreover, oxidative stress in turn generates inflammatory responses of cytokine and chemokine mediators, thereby promoting generalized peroxisomal dysfunctions, and, therefore, cell loss during the inflammatory demyelinating disease [21] . Enhanced oxidative stress was found by different groups using the X-ALD mouse model [24, 26] . Moreover, C22:0, C24:0 and C26:0 were shown to induce neuronal damage by causing morphological and functional changes in mitochondria of a human neuroblastoma cell line [27] . Furthermore, fibroblasts exposed to C26:0 exhibit enhanced generation of ROS, which is coupled with the decreased mitochondrial membrane potential (Δψ m ) [24] . Oxidative stress in X-ALD has been documented as enhanced lipid peroxidation, reduced plasmalogen level, and decreased antioxidant defense resulting in increased GSSG/GSH ratio [20, 26, [28] [29] [30] [31] [32] .
Therefore, an alternative strategy to reveal the role of VLCFA in the pathogenesis of X-ALD is to analyze VLCFA-associated events triggering the onset of X-ALD pathogenesis (see for recent reviews [33, 34] ).
ABCD1 gene expression in the brain of adult mouse and human is mostly restricted to astrocytes, microglia cells, and oligodendrocytes [35] . Dysfunction of ABCD1 in glial cells seems to have a special role in the pathogenesis of X-ALD, since both oligodendrocytes and astrocytes are important for myelination. Astrocytes influence the myelination via secretion of factors or formation of cell-cell contacts to oligodendrocytes [36] . Furthermore, astrocytes are known to synthesize lipids and supply these to other cells for myelination and synaptogenesis [37, 38] . Previously, we could already demonstrate that excess of VLCFA is toxic for neural cells, especially for glial cells [39, 40] . In these studies we revealed that VLCFA cause detrimental changes in hippocampal neurons, astrocytes and oligodendrocytes by disturbing the intracellular Ca 2+ homeostasis and mitochondrial functions, which finally lead to death of cells. The strongest impairment was seen in the myelin-producing oligodendrocytes. However, until now no studies have been done concerning the toxicity of VLCFA in neural cells of the Abcd1-knockout mouse model. The degradation of VLCFA is orchestrated by the peroxisomal and mitochondrial β-oxidation pathways (see for review [41] ). This combined degradation by both organelles is disturbed in X-ALD. From this fact the important question arises: Does the biogenesis of mitochondria respond to the defective ABCD1 protein, leading to mitochondrial functions in the ABCD1-deficient phenotype that are different from that of the normal phenotype? Indeed, there are the following controversial reports on alterations of mitochondrial functions in adrenoleukodystrophy. On the one side, structural abnormalities of mitochondria in cells of X-ALD mice have been proposed to indicate impaired mitochondrial functions [42, 43] , whereas on the other side it was reported that normality in size, structure and localization of mitochondria in muscle can be detected in an ABCD1-deficient mouse model for X-ALD [44] . Rates of oxygen uptake of phosphorylating isolated skeletal muscle mitochondria from ABCD1-deficient and wild-type mice also did not differ [44] . In contrast, experiments with permeabilized spinal cord slices of the ABCD1-deficient mouse model revealed a decrease of the phosphorylating respiration by 20 to 25% [45] . This decrease in the phosphorylating respiration might be attributed to an oxidatively impaired F O F 1 -ATP synthase activity [45] and/or to the noxious activity of an enhanced level of VLCFA in the spinal cord slice tissue. The latter view is indicated by the observation that the oligomycin-sensitive respiration of fibroblast cultures prepared from control ABCD1-deficient mice (metabolizing galactose) was similar, but decreased in the presence of 50 μM of C26:0 [45] . Moreover, reduced contents of mitochondria were found in neural tissues from the spinal cords of the same mouse model [46] .
Despite the fact that X-ALD is severely manifested in neural tissue, most studies in the field of X-ALD basic research were done using Abcd1 −/− fibroblasts of patients or mice. Therefore, the present study was designed to illuminate the influence of VLCFA accumulation on glial cells of wild-type control mice and those from an X-ALD mouse model (Abcd1 −/− ). Here, we investigated the influence of VLCFA on the cellular properties of ROS production, various mitochondrial parameters, cellular Ca 2+ handling, and the reduction of a tetrazolium electron acceptor (WST-1) to the water-soluble formazan dye, and, finally, induction of cell death in astrocytes.
Here, we report that astrocytes from wild-type control and ABCD1-deficient mice, which were exposed to supraphysiological concentrations of the VLCFA (C22:0, C24:0 and C26:0) exhibit multiple impairments of the astrocytic energy metabolism. In contrast, the functional parameters of mitochondria from brain tissue of Abcd1 −/− mice do not differ from those of the wild-type control. This finding suggests that a defective peroxisomal ABCD1 exerts no adaptive pressure on the mitochondria. Moreover, mitochondria and astrocytes respond to VLCFA with different lengths of the hydrocarbon chain in a different manner, indicating that mitochondria are not the only target of detrimental VLCFA activities in astrocytes. In summary, astrocytes from Abcd1 −/− mice respond more sensitively to VLCFA than those from wild-type control. Thus, long-term application of VLCFA causes higher ROS generation and a stronger in situ depolarization of mitochondria. In addition, VLCFA diminished severely in Abcd1 −/− astrocytes the capability to reduce the tetrazolium electron acceptor (WST-1) to the formazan dye. Taken together, these findings may help to establish new concepts for finding treatments for X-ALD.
Materials and methods

Materials
Dulbecco's modified Eagle's medium (DMEM), penicillin/streptomycin and fetal calf serum (FCS) were obtained from Biochrom AG (Berlin, Germany). The fluorescent dyes Fura-2AM, dihydroethidium (DHE) and Rhodamine 123 (Rh123) as well as Pluronic and the dead cell apoptosis kit with annexin V FITC and propidium iodide (PI) were from Molecular Probes Invitrogen (Karlsruhe, Germany). Water-soluble tetrazolium salt WST-1 was from Roche (Mannheim, Germany). Behenic acid (C22:0), lignoceric acid (C24:0), and cerotic acid (C26:0) were obtained from Larodan Fine Chemicals AB (Malmö, Sweden). All other chemicals were from Sigma Aldrich (Taufkirchen, Germany).
Cell culture and treatment
All experiments with animals conformed to the guidelines of Sachsen-Anhalt (Germany) on the ethical use of animals, and all efforts were made to minimize the number of animals used. After decapitation of newborn mice (C57BL6/Abcd1 −/− , P1-P3), the meninges were removed and the brains minced into small pieces using surgical scalpel. Brain pieces were washed twice with cold preparation buffer (low chloride PBS with modif-solution) and digested with 4 mg/ml trypsin type XI for 7 min at 37°C. Digestion was stopped by adding DMEM media (supplemented with 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomycin). The digested tissue was washed again in preparation buffer and afterwards triturated by passing the pieces through a Pasteur pipette for several times. The cell suspension was filtered by a tube-top cell strainer (pore size 100 μm) and centrifuged for 5 min at 500 g. After resuspending the cell pellet in culture media (DMEM supplemented with 10% FCS, 100 U/ml penicillin, and 100 μg/ml streptomycin), cells were plated onto culture flasks and incubated by 37°C and 10% CO 2 . The medium was changed in intervals of two days and 24 h before the experiment. Cells were used 14-20 days after plating. Possible contamination of the astrocyte cell preparations by microglia was estimated by staining for the marker proteins GFAP and IB4, respectively. Resulting micrographs displayed a low content of microglia in the astrocyte preparation, amounting to less than 5% (not shown).
For the treatment of cells, VLCFA (C22:0, C24:0 and C26:0) were dissolved in methanol/chloroform and further solubilized in α-cyclodextrin solution (1 mg/ml) by sonification. α-Cyclodextrin solution serves as vehicle, and was supplemented with an aliquot of VLCFA-free methanol/chloroform mixture [47] . Pre-treatment of cells was done by changing the culture medium with FCS to culture medium without FCS and adding 20 μM or 40 μM of VLCFA for 24 h, concentrations measured in human brain demyelinating plaques (60 μM; [19] ). For acute treatment, VLCFA were applied during the measurements in the buffer used. [48] . Rh123 accumulated in mitochondria was measured via the increase of Rh123 fluorescence over the mitochondria-free nucleus of cells after depolarization evoked by combined application of the uncoupler carbonyl cyanide 4-trifluoromethoxyphenylhydrazone (FCCP, 4 μM) and the F O F 1 -ATPase inhibitor oligomycin (10 μM). The FCCP/oligomycin-mediated depolarization and therefore Rh123 release under control conditions was taken as 100%.
The generation of ROS was carried out by the oxidation of dihydroethidium (DHE, 1 μM) to the ethidium cation, which binds to nuclear DNA. For measuring ROS production the dye was applied together with the test substances directly to the cells and excited at 520 nm with emission at 590 nm.
Isolation of mitochondria, fluorimetric and oxygraphic measurements
Mitochondria were prepared from the brains of 6 month old C57BL6 wild-type and Abcd1 −/− mice and kept at a temperature of 4°C. After removal, the brains were washed in ice-cold NaCl solution (0.9%) and afterwards homogenized in isolation buffer (320 mM sucrose, 10 mM Tris/HCl, 0.5 mM EDTA, 0.5 mM EGTA, 0.5% BSA, pH 7.4). The homogenate was centrifuged at 2000 g for 4 min. The pellet of mitochondria was obtained by centrifugation of the supernatant at 2000 g for 4 min and thereafter at 12,000 g for 11 min. To purify mitochondria, a Percoll gradient (10%, 15%, 24%) was used and afterwards the mitochondria were washed in wash buffer (320 mM sucrose, 10 mM Tris/HCl, pH 7.4). Generation of ROS in isolated mitochondria was determined by oxidation of non-fluorescent Amplex Red to fluorescent Resorufin monitored by the Perkin-Elmer Luminescence spectrometer LS 50 (excitation at 560 nm, emission at 590 nm). Therefore, mitochondria (0.2 mg/ml) were kept in incubation buffer (125 mM KCl, 10 mM Tris/HCl, 5 mM KH 2 PO 4 , pH 7.4) supplemented with Amplex Red (5 μM), succinate/glutamate (5 mM), horseradish peroxidase (2 U/ ml) and superoxide dismutase (10 U/ml). Treatment of mitochondria with test substances was started after 5 min of reverse electron transport-(RET)-mediated ROS formation [49, 50] for a time period of 10 min. In addition, ROS generated by the forward electron transport (FET) was also measured with the Amplex Red assay. In this case, mitochondria were supplied with glutamate plus malate (5 mM each) as substrates. The fluorescence signal of Resorufin was calibrated by sequential additions of known amounts of H 2 O 2 (up to 75 pmol). Ca 2+ uptake and release from isolated mitochondria were assayed using the fluorescent dye Calcium Green-5N (CaG5N). Mitochondria (0.5 mg/ml) were incubated in incubation buffer containing malate (5 mM), glutamate (5 mM) and CaG5N (0.1 μM) and were treated by incremental intermittent pulses (20 nmol CaCl 2 /mg of protein) of CaCl 2 -containing stock solution (2 mM CaCl 2 ) until the PTP opened. Resulting changes in Ca 2+ concentration in the incubation buffer were detected by CaG5N fluorescence using wavelengths for excitation and emission of 506 nm and 532 nm, respectively. Mitochondrial respiration was measured using an Oroboros Instruments Oxygraph® (Innsbruck, Austria) at 37°C. For this purpose, isolated mitochondria (0.5 mg of protein per ml) were suspended in standard incubation medium supplemented with glutamate plus malate (5 mM each) as substrates.
Assay of cell death
For the determination of the mechanism of cell death, the challenged cells were incubated with the VLCFA C22:0, C24:0 and C26:0 (40 μM) in culture medium (without FCS) for 24 h and afterwards stained with FITC annexin V and PI for 15 min. Stained cells were detected with a Zeiss LSM 510 META confocal laser scanning microscope with the respective filters for the fluorescence excitation/emission maxima (FITC annexin V: 494 nm/518 nm and PI: 535 nm/617 nm). For quantification, the number of FITC annexin V-and PI-stained cells was calculated in correlation to the total cell number.
Reduction of tetrazolium electron acceptor WST-1
To assess the reducing capability of VLCFA-treated astrocytes, cells were exposed to the water-soluble, membrane-impermeable tetrazolium salt WST-1 (2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium) plus 1-methoxy phenazine methosulphate [51] . The latter mediates the electron transport from the cytosolic, and reduced pyridine nucleotides (NAD(P)H) to the extracellular tetrazolium salt. Thereby, the pale-colored tetrazolium salt becomes converted into a deep-colored-formazan dye.
Primary astrocytes seeded at a density of 5 × 10 4 cells/well into 96-well culture plates were treated with various VLCFA concentrations (10 μM, 20 μM and 40 μM) in culture media without FCS. After incubation for 24 h, an aliquot of WST-1 reagent (diluted 1:10) was added to each well and after additional 4 h of incubation, the absorbance (450 nm) of the formed formazan dye was measured.
Thiobarbituric acid reactive substances (TBARS) assay
Lipid peroxidation was determined by TBARS formation. Briefly, 100 μl of samples was incubated with 250 μl of 0.36% thiobarbituric acid (in 20% acetic acid, pH 3.5) at 95°C for 60 min. The mixture was allowed to cool down on ice for 5 min and was then centrifuged at 1100 g for 15 min. The pink-stained TBARS in the supernatant was determined at 532 nm absorbance. A calibration curve was established using a malondialdehyde (MDA) standard. TBARS was given as equivalent of nmol MDA/mg of protein.
Statistical analysis
All data are represented as mean ± SEM of at least three different experiments and preparations. For statistical analysis Student's t-test was used. A p value less than 0.05 was considered as statistically significant (p b 0.05).
Results
VLCFA increase the generation of reactive oxygen species (ROS) of astrocytes and enhance the oxidative stress
Several reports demonstrate increased oxidative stress in tissues of X-ALD patients [52, 53] . Therefore, we studied first the intracellular ROS formation in astrocytes from a X-ALD mouse model (Abcd1 −/− ) and wild-type mice, treated with 40 μM VLCFA. We used the ROSsensitive probe DHE. Fig. 1 shows that the ROS formation in wild-type cells was increased, when cells were treated with C22:0 (1.4-fold), C24:0 (1.5-fold) and C26:0 (2.0-fold). All our data obtained are referred to that of the control condition (indicated as the dashed line), where the astrocytes were treated only with the vehicle α-cyclodextrin (1 mg/ml). Comparable results were achieved with Abcd1 −/− cells, indicated as 1.3-, 1.4-, and 2.3-fold increase of ROS production with C22:0, C24:0 and C26:0, respectively. ROS generation was most strongly enhanced with C26:0, but the increase was significantly higher in Abcd1 −/− cells than in wild-type cells. Accumulation of VLCFA in patients suffering from X-ALD persists over long time periods. Along this line, we next analyzed the effect of longer-term application of VLCFA (24 h incubation with 20 μM before measurement with 40 μM VLCFA) on the ROS generation. In pretreated wild-type astrocytes, the amount of cellular ROS production remained almost unchanged as compared to the short-term exposure to VLCFA, whereas pre-treatment of Abcd1 −/− astrocytes with VLCFA strongly enhanced the ROS formation ( partial restoration of Δψ m , resulting from the F O F 1 -ATPase-dependent hydrolysis of glycolytically formed ATP. As previously reported [48] , the amount of releasable Rh123 is reciprocally related to deenergizing activity of a mitochondrial poison. Moreover, the estimated Δψ m , which was observed when wild-type astrocytes were exposed to the vehicle α-cyclodextrin (1 mg/ml as solvent control) was taken as control (given as 100%; Fig. 3 (Fig. 3) . In contrast, in Abcd1 −/− cells pre-treatment with C22:0 or C24:0 resulted in a potentiated decrease of the Δψ m up to 40% ± 2.6 and 39% ± 2.6, which is statistically significantly different from the decrease detected without pre-treatment (28% ± 3.1 and 30% ± 3.5). Pre-treatment with C26:0 was without effect on the Rh123 release, as seen after the subsequent addition of 40 μM C26:0 Abcd1 −/− cells.
VLCFA directly affect the inner membrane of isolated brain mitochondria
It is quite likely that the decrease of Δψ m shown in Fig. 3 results from the protonophoric activity of VLCFA and, in addition, from a partial deregulation of the electron transport chain by VLCFA (most likely for C24:0 or C26:0) [54] . To verify further a direct influence of VLCFA on the inner mitochondrial membrane (IMM), we studied the effect of VLCFA on the electron transport chain associated ROS generation with isolated mouse brain mitochondria (MBM). We investigated firstly with MBM the effect of VLCFA on ROS generation, which is associated with the forward electron transport (FET). This was done by fluorimetric recording of the H 2 O 2 released from respiring MBM into the incubation medium using the Amplex Red assay. To analyze the influence of VLCFA on ROS production by FET, the slope of the increase of Resorufin fluorescence obtained after addition of VLCFA was referred to the slope recorded in the absence of VLCFA (Fig. 4A) . With respect to the ROS generation and its modulation by VLCFA, no significant difference between the MBM from wild-type and Abcd1 −/− mice was found (Fig. 4B) . Moreover, a significant increase in the FET-associated H 2 O 2 release was detectable only with C22:0-treated mitochondria, both from wild-type and Abcd1 −/− mice (2.6-fold and 2.7-fold above control), whereas C24:0 and C26:0 showed almost no effect on the FET-associated H 2 O 2 release.
Since the ROS production connected with the reverse electron transport (RET) responds very sensitively to the decrease of Δψ m , we determined, in addition, the possible effect of VLCFA on the H 2 O 2 release supported by RET. For that, MBM were supplied with succinate plus glutamate and the released H 2 O 2 was measured in the absence or presence of VLCFA. It is an important feature of isolated neuronal mitochondria that the succinate dehydrogenase is inhibited by endogenous oxaloacetate [55] . Therefore, glutamate was added to remove oxaloacetate by transamination to aspartate. This avoids any inhibition of succinate dehydrogenase during succinate oxidation.
Oxidation of succinate by complex II of the electron transport chain builds up a high Δψ m , which enables the uphill transport of the electrons from complex II to complex I. Consequently, a depolarization of the IMM leads to a reduction of the RET-supported ROS production, as we have reported before [50, 54] . The data obtained are summarized in Fig. 4C . The vehicle α-cyclodextrin had no effect on ROS production and was used as control. Similar to the FET-dependent ROS production, only C22:0 exerts a strong effect on the RET-based ROS production. This effect was not significantly different between MBM of wild-type mice (C22:0 29% ± 2) and Abcd1 −/− mice (C22:0 33% ± 12). The uncoupler FCCP evoked an almost complete reduction of RET-dependent ROS production with remaining 9% ± 2 (Wt) and 14% ± 2 (Abcd1
). The different effects of VLCFA on the FET-and RET-dependent ROS production are also reflected in their influence on the rate of the electron transport in the IMM, indicated as change of the resting respiration. Thus, the rate of the resting respiration of wild-type MBM shows that the addition of C22:0 to MBM supplied with glutamate plus malate as hydrogen-delivering substrates, stimulates the resting respiration about 2-fold, clearly indicating the depolarization of the IMM (Fig. 5A) . In comparison to C22:0, stimulation of the resting respiration by C24:0 is much lower, and absent for C26:0 additions. Moreover, when FCCP was added in the absence of VLCFA, the increase of the resting respiration was high. Remarkably, a subsequent addition of C22:0 decreased the FCCP-uncoupled respiration, indicating the ability of VLCFA to de-regulate the electron transport.
In addition, the effect of VLCFA was examined on the ADP-stimulated respiration (state 3) of MBM isolated from wild-type and Abcd1 −/− mice.
Both types of mitochondria exhibit a high rate of ADP-dependent respiration, with no significant difference between wild-type and Abcd1
−/− mice. Even in the case of mitochondria isolated from one-year-old Abcd1 −/− mice, state 3 respiration is similar to that seen in mitochondria from adult wild-type mice (Table 1) . From Fig. 5B it can be seen that VLCFA inhibit as a function of the hydrocarbon-chain length the state 3-respiration in both types of mitochondria. In contrast, the vehicle (α-cyclodextrin) was nearly without effect (data not shown). Taken together, C22:0 exerts the strongest effects on MBM, clearly indicated as mild uncoupling of the resting respiration and the inhibition of the FCCP-uncoupled or state 3-respiration. These findings clearly reveal pronounced effects of C22:0, first the decrease of Δψ m and second, a partial impairment of electron transport to oxygen. the initial level. Consequently, overriding the CRC is indicated by the sudden increase in CaG5N fluorescence, resulting from the opening of PTP (Fig. 6A) . Interestingly, mitochondria from Abcd1 −/− mice showed slightly, but significantly higher CRC than those from wild-type mice (Abcd1 −/− with 125% ± 4.2 compared to wild-type with 100% ± 6.6; see analysis in Fig. 6B ). Application of the VLCFA C22:0, C24:0 and C26:0 (40 and 80 nmol/mg protein corresponding to 20 and 40 μM) caused in MBM from wild-type and Abcd1 −/− mice a general premature opening of the PTP, quantified by lowering of the CRC (Fig. 6B) . Again, the strongest effect was found with C22:0 (80 nmol/mg protein), where the reduction was 32% ± 3.6 in wild-type and 48% ± 3.6 in Abcd1 −/− mitochondria. Thus, VLCFA diminish the CRC by sensitization MBM for PTP opening. However, even in the presence of VLCFA, CRC is higher in ABCD1 −/− MBM compared to controls. Taking into consideration that VLCFA depolarize control and ABCD1 −/− MBM similarly (Fig. 3) , a lower VLCFA-linked decrease of CRC in ABCD1 −/− MBM may indicate that VLCFA delay the opening of PTP.
VLCFA-induced intracellular Ca 2+ response is diminished in Abcd1
−/− astrocytes Besides their involvement in pathways leading to cell death and cellular ROS production, mitochondria also play an important role in Ca 2+ signaling and storage. As mentioned above, we found that mitochondria of Abcd1 −/− mice exhibit a slightly higher CRC than mitochondria from wild-type mice (Fig. 6 ). Therefore, we made a comparative analysis of the influence of C22:0, C24:0 and C26:0 on changes in the cytosolic Ca 2+ level in astrocytes. Representative traces in Fig. 7A depict the (Fig. 7) are considered in the discussion.
Effects of VLCFA on the regeneration of reduced pyridine nucleotides (NAD(P)H) by astrocytes
The survival of cultured cells can be determined by measuring the reductive conversion of the tetrazolium-electron acceptor to a formazan dye, which absorbs at 450 nm. Tetrazolium reduction depends on the activity of NAD(P)H-linked oxidoreductases, which largely operate in the cytosolic compartment of the cells [51] . Tetrazolium-reduction was used to examine the impairment of the regeneration of reduced pyridine nucleotides in VLCFA-treated astrocytes. The assay is based on a water-soluble and membrane-impermeable tetrazolium salt (WST-1) and uses 1-methoxy phenanzine methosulphate as mediator to shuttle electrons from cytosolic NAD(P)H across the plasma membrane to the electron acceptor WST-1. Consequently, WST-1 reduction reflects the rate of conversion of the cellular oxidized pyridine nucleotides into their reduced form (NAD(P)H). Rates of WST-1 reduction by astrocytes, which were pretreated with supraphysiological concentrations of VLCFA, are shown in Fig. 9 . The data clearly reveal that in VLCFA-treated ABCD1 −/− astrocytes, the ability to regenerate NAD(P)H is lower. In addition, C24:0 and C26:0, even at the lowest concentration applied (10 μM), have a more pronounced effect than C22:0. In addition, brain mitochondria isolated from WT and ABCD1 −/− mice do not differ in their ability to reduce the tetrazolium salt (data not shown). This was measured with 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium (MTT) suggesting that the VLCFA exert their detrimental activity on the pyridine nucleotide regeneration largely in the cytosolic compartment.
VLCFA induce apoptosis in astrocytes
Opening of the PTP is the precondition of the mitochondria-guided apoptosis. Thus, we tested whether VLCFA initiate the apoptosis in astrocytes. We measured the release of the cytosolic lactate dehydrogenase into the medium. 24 h incubation with 40 μM of VLCFA evoked a significant lactate dehydrogenase release in wild-type and Abcd1 −/− astrocytes. This therefore indicates the toxic activity of the C22:0, C24:0 and C26:0 on neural cells (data not shown). Furthermore, the mechanism of VLCFA-induced cell death was studied in detail via annexin V and PI staining in Abcd1 −/− astrocytes after 24 h incubation with the fatty acids. We found that most of the fluorescence-marked cells were stained with annexin V (columns marked with hatching; C22:0, 80%; C24:0, 94%; C26:0, 84% of stained cells), which indicates the apoptotic route of cell death. Only a small portion exhibited PI fluorescence (columns marked with crossings), reflecting necrosis (Fig. 10 ).
Discussion
Since X-ALD is a neurodegenerative disease, we used astrocytes and isolated brain mitochondria from Abcd1-knockout mice in our studies. While ABCD1 expression was shown for astrocytes, microglia, oligodendrocytes and neurons [35, 59] , most studies published on the detrimental activity of VLCFA in tissues were made with Abcd1 −/− fibroblasts.
Here we addressed particularly the question whether the energy metabolism has vulnerability to exposure to VLCFA C22:0, C24:0 and C26:0 in wild-type astrocytes (control) and those prepared from the brain of an ABCD1-deficient mouse model. The C26:0 VLCFA is up to 4-6-fold enhanced in patients suffering from X-ALD [2] . The concentrations of applied VLCFA (20 and 40 μM) are comparable to those used in other studies [31, 39] . Furthermore, there is an ongoing debate on mitochondrial abnormalities in X-ALD and other peroxisomal disorders, like Zellweger syndrome [42, [60] [61] [62] . This interest is supported by the cooperation of mitochondria and peroxisomes in the degradation of VLCFA [41] . Thus, a defective peroxisomal β-oxidation in Abcd1 −/− cells raises the question, whether mitochondria display a compensatory response to the peroxisomal defect. For that reason, we focused our attention also on possible alterations of mitochondrial parameters (ROS generation, state 3 respiration, CRC, and Δψ m ) in mitochondria prepared from the brain tissue of the ABCD1-deficient mouse model. −/− astrocytes to VLCFA, two incubation strategies were applied in our study: (1) Measurement of VLCFA-sensitive parameters after acute exposure to supraphysiological concentrations of VLCFA.
(2) 24 h-pretreatment of astrocytes with relatively low concentrations of VLCFA, followed by the acute exposure to a higher concentration of VLCFA. The second strategy may have the advantage that pretreated cells become sensitized to deleterious activities of VLCFA. We are aware that this strategy only poorly mimics the situation of the interaction of neural cells with VLCFA in patients suffering from X-ALD. In addition, mitochondria from one-year-old Abcd1 −/− mice were examined for their response to ADP or ADP plus C22:0 (Table 1) . State 3 respiration, i.e. oxidative phosphorylation was not affected.
Structure-dependent VLCFA-toxicity is different for astrocytes and mitochondria
When applying the VLCFA C22:0, C24:0 and C26:0 to astrocytes or to isolated brain mitochondria, there was a surprising observation with regard to the hydrocarbon chain length of VLCFA. Thus, C26:0 exerts similar or even higher detrimental activity on astrocytes like C22:0 or C24:0 does (Figs. 1, 3 , and 10), whereas C26:0 was nearly without any effect on mitochondria (Figs. 4, 5 and 6 ). It can be speculated that the pronounced detrimental activity of C22:0 on mitochondria results from its easier escape from the cyclodextrin vesicles to mitochondria combined with a higher flip-flop mobility in the IMM. The latter property would explain the higher protonophoric activity of C22:0 on the IMM of mitochondria (Figs. 4C and 5A) .
It is generally accepted that mitochondria and peroxisomes are important sites of the ROS generation in cells (for review see [63] ). Therefore, a further question arises: Do astrocytes from Abcd1 −/− and from wild-type mice differ with respect to the ROS generation, particularly when they are exposed to pathophysiological concentrations of VLCFA? Here, we show that the intracellular ROS generation in untreated astrocytes from wild-type and Abcd1 −/− mice are not different from each other and, in addition, they are similarly stimulated by acute exposure to VLCFA (Fig. 1) . Nevertheless, the highest induction of the ROS generation was found in astrocytes of Abcd1 −/− mice during shorttime exposure with C26:0. Surprisingly, when Abcd1 −/− astrocytes, pretreated with a lower concentration of VLCFA for 24 h, were exposed thereafter to a higher concentration of VLCFA, their ROS generation was similarly increased by C22:0, C24:0 or C26:0. This finding might be explained in the light of VLCFA-associated decreased regeneration of oxidized pyridine nucleotides (Fig. 9) as follows: It seems likely that pretreated Abcd1 −/− astrocytes exhibit a diminished NAD(P)H-dependent regeneration capacity of oxidized glutathione. Consequently ROS production becomes to a lesser extent inactivated by the cellular glutathione peroxidase. This conclusion could also explain that oxidative stress is obviously higher in Abcd1 −/− astrocytes, as indicated by stronger lipid peroxidation (Fig. 2) . Similar to the in situ Δψ m measurements, the effect of VLCFA in Abcd1 −/− astrocytes was dramatically potentiated when cells were treated with these fatty acids over a longer time period, indicated by enhanced reduction of Δψ m in mitochondria of Abcd1 −/− astrocytes compared to cells from wild-type mice (Fig. 3) . 
VLCFA-induced impairment of the electron transport as source of ROS generation
An impairment of the electron flow in the respiratory chain by free fatty acids enhanced the ROS generation in the forward mode (FET), whereas the depolarization of IMM by fatty acid-associated mild uncoupling decreased ROS formation in the reverse mode (RET) [64] . Therefore, possible effects of VLCFA on the IMM were studied with isolated brain mitochondria from wild-type and Abcd1 −/− mice. In both types of mitochondria, the response to VLCFA was remarkably similar for i) increase of the FET-driven ROS production (Fig. 4B ) and for ii) decrease of the RET-driven ROS generation (Fig. 4C) . These responses were most prominent with C22:0. In contrast, a severe Δψ m decrease in wild-type astrocytes occurred after acute exposure to VLCFA, where for C26:0 a surprising observation was made, since C26:0 has no significant detrimental activity on isolated mitochondria (Figs. 4 and 5) . Moreover, in contrast to the ROS measurements in astrocytes, where C22:0, C24:0 and C26:0 exert, after long-time exposure, a similarly strong effect on ROS production, an acute exposure of brain mitochondria to C22:0 has the largest effect. Therefore, it is conceivable that besides the peroxisomes, VLCFA also activate further non-mitochondrial sources of ROS generation in astrocytes. Finally, we have to consider the following: since in the in vivo situation brain mitochondria are predominantly supplied by NADH-donating substrates, the effects of VLCFA on the FET-dependent ROS generation are of much higher relative physiological relevance than the influence on RET.
We could verify that especially C22:0 directly influences the IMM, as shown by the increase of the resting respiration and impairment of state 3 respiration (Fig. 5) . The first activity results from mild uncoupling, and the second activity is due to impaired electron transport and inhibition of the combined activity of F O F 1 -ATP synthase plus adenine nucleotide translocase. Interference of fatty acids with the mitochondrial electron transport has been well documented [50, 65, 66] and is best explained by a destabilization of the membrane through incorporation of VLCFA and, possibly, by dissociation of cytochrome c from the IMM [67] [68] [69] .
Energy-dependent parameters are not different for brain mitochondria isolated from wild-type and Abcd1
−/− animals Notable is our finding that the energy-dependent parameters (Δψ m , ADP-dependent respiration and ROS generation) in untreated brain mitochondria either measured in situ or in vitro do not differ for wild-type and Abcd1 −/− mice. This suggests that the loss of the ABCD1-protein from peroxisomes has no direct effect on these functional mitochondrial parameters [45] . This is in line with our observation that Δψ m and ROS production are comparable in untreated astrocytes (Figs. 1, 3, 4 , and 5), whereas the long-term treatment of cells with VLCFA resulted in a significantly stronger impairment in Abcd1 knockout. We have to come back to the increased ROS generation in VLCFAtreated astrocytes (Fig. 1) , especially in Abcd1 −/− astrocytes after exposure to C26:0, which is highly increased in X-ALD patients. This indicates an increased vulnerability of Abcd1 −/− cells to C26:0 and a crucial role of C26:0 in the pathogenesis of X-ALD. Furthermore, when Abcd1 −/− astrocytes were treated with VLCFA for a longer period of time the amount of ROS production more dramatically increased in these cells than in VLCFA-treated wild-type astrocytes in which the ROS formation remained almost the same as in acutely stimulated wild-type cells. A comparable effect of enhanced ROS production was shown for Abcd1-silenced 158 N oligodendrocytes, in which VLCFA incubation leads to a stronger formation of superoxide anions and hydrogen peroxide as compared to non-silenced cells [26] . These results indicate a link between oxidative stress and ABCD1 deficiency that may also be the cause of the increased level of lipid peroxidation detected in Abcd1 −/− astrocytes (Fig. 2) . Long-term treatment of astrocytes with VLCFA potentiated the cellular effect of the fatty acids (Fig. 7) 
VLCFA promote the cell death in astrocytes
Moreover, mitochondrial Ca 2+ accumulation can trigger the disturbance of the Δψ m , which further favors the opening of the PTP [71] . Thus, we studied PTP opening by estimating the CRC, which was found to be slightly higher in mitochondria from Abcd1 −/− mice (Fig. 6 ). This could be related to the decreased Ca 2+ rise in Abcd1 −/− astrocytes after acute VLCFA application. It is conceivable that due to the higher CRC of mitochondria from Abcd1 −/− mice a higher amount of the intracellular Ca 2+ release was buffered by these mitochondria, resulting in a weaker Ca 2+ response in Abcd1 −/− cells. Moreover, we found that the reduction of the Δψ m due to VLCFA exposure, especially with C22:0, lowered the CRC and sensitized for opening of PTP. This is in agreement with recent reports indicating an increased sensitivity of X-ALD patient's fibroblasts to opening of PTP and consequent cell death, involving oxidation of the pore components cyclophilin D and ATP synthase [25] . Indeed, oxidative stress as well as intracellular Ca 2+ overload are PTP opening trigger events initiating cell death and are therefore important mediators of toxicity [72] . The property of VLCFA to induce the death of Abcd1 −/− astrocytes increased with the length of the hydrocarbon chain of VLCFA. A similar relation between the cytotoxicity of fatty acids and their chain length has been already reported for polyunsaturated fatty acids [73, 74] . Thus, again, C26:0, which has the lowest detrimental activity on mitochondria (Figs. 4C, 5 and Fig. 6 ), exerts the highest cell toxicity (see also [39] ). This finding indicates that the VLCFA-induced astrocytic cell death is not exclusively due to a detrimental effect of VLCFA on mitochondria.
Conclusion on toxicity of VLCFA and therapeutic outlook
In summary, astrocytes from Abcd1 −/− mouse respond more sensitively to VLCFA, mainly indicated by the cellular ROS generation (Fig. 1) , in situ depolarization of mitochondria (Fig. 3) and reduced reduction of tetrazolium (Fig. 9) . The latter feature, the VLCFA-induced decrease of tetrazolium reduction by Abcd1 −/− astrocytes, is of special significance. This property was reported here for the first time. This finding suggests that in contrast to wild-type astrocytes, VLCFA dramatically diminish the regeneration of NAD(P)H in Abcd1 −/− astrocytes.
Usually, in the literature the cellular reduction capacity of tetrazolium derivatives is taken prima vista as a measure of cell proliferation/ survival. But our finding is suggestive for the hypothesis that an impaired regeneration of NAD(P)H contributes to the shortening of the life-expectancy of Abcd1 −/− astrocytes, because most likely the glutathione-dependent inactivation of lipid hydrogen peroxides and hydrogen peroxide are affected. Consequently, VLCFA-exposed Abcd1 −/− astrocytes suffer more under oxidative stress than wild-type astrocytes. Future work is required for further enlightening of this concept. In addition, a disturbed Ca 2+ signaling seems to be involved in the pathogenesis of X-ALD. Thus, Abcd1 −/− astrocytes displayed a much lower intracellular Ca 2+ reaction in response to acute VLCFA application (Fig. 7) . In contrast we observed lack in difference in mitochondrial respiratory functions in control MBM and in Abcd1 −/− MBM. Ca
2+
, which plays a key role in neural signaling in the brain, is of paramount importance for the control of neurodegenerative diseases, like Alzheimer's disease, Parkinson's disease, and Huntington's disease [75] . Thus, the weaker Ca 2+ response to VLCFA in Abcd1 −/− astrocytes highlights a further physiological parameter and indicates a therapeutic target for X-ALD.
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